Purine enzymes in patients with rheumatoid arthritis treated with methotrexate

Annals of the Rheumatic Diseases

Volumn 61, Issue 12, 2002, Pages 1060-1064

  Van Ede, A E ^a   Laan, R F J M ^a   De Abreu, R A ^a   Stegeman, A B J ^a   Van de Putte, L B A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DEAMINASE; ALANINE AMINOTRANSFERASE; CORTICOSTEROID; FOLIC ACID; FOLINIC ACID; HOMOCYSTEINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PURINE NUCLEOSIDE PHOSPHORYLASE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; HUMAN; LABORATORY TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTICENTER STUDY; PRIORITY JOURNAL; PURINE METABOLISM; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; TREATMENT OUTCOME;

ADENOSINE DEAMINASE; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; FEMALE; FOLIC ACID; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LEUCOVORIN; MALE; METHOTREXATE; MIDDLE AGED; NUCLEOTIDASES; PURINE-NUCLEOSIDE PHOSPHORYLASE; PURINES; REGRESSION ANALYSIS;

EID: 0036893528     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.12.1060     Document Type: Article

References (25)

1. van Ede AE, Laan RFJM, Blom HJ, De Abreu RA, van de Putte LBA. Methotrexate in rheumatoid arthritis: An update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum 1998;27:277-92.
2. Cronstein BD. The mechanism of action of methotrexate. Rheum Dis Clin North Am 1997;23:739-55.
3. Markert ML. Purine nucleoside phosphorylase deficiency. Immunodeficiency Reviews 1991;3:45-81.
4. Giblett ER, Ammann AJ, Wara DW, Sandman R, Diamond LK. Nucleosidephosphorylase deficiency in a child with severly defective T-cell immunity and normal B-cell immunity. Lancet 1975;i:1010-13.
5. Sandman R, Ammann AJ, Grose C, Wara DW. Cellular immunodeficiency associated with nucleoside phosphorylase deficiency. Clin Immunol Immunopathol 1977;8:247-53.
6. Levinson DJ, Chalker D, Arnold WJ. Reduced purine nucleoside phosphorylase activity in preparations of enriched T-lymphocytes from patients with systemic lupus erythematosus. J Lab Clin Med 1980;96:562-9.
7. Rich KD, Arnold WJ, Palella T, Fox IH. Cellular immune deficiency with autoimmune haemolytic anaemia in purine nucleoside phosphorylase deficiency. Am J Med 1979;67:172.
8. Carpella-de Luca E, Aiuti F, Lucarelli P, Bruni L, Baroni CD, Imperato C, et al. A patient with purine nucleoside phosphorylase deficiency, selective T-cell deficiency and autoimmune haemolytic anaemia. J Pediatr 1978;93:1000.
9. Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ. Adenosine-deaminase deficiency in two patients with severely impaired immunity. Lancet 1972;ii:1067-9.
10. Johnson SM, North ME, Asherson GL, Allsop J, Watts RWE, Webster ADB. Lymphocyte purine 5′-nucleotidase deficiency in primary hypogammaglobulinemia. Lancet 1977;i:168-70.
11. Edwards NL, Hagilavy D, Cassidy JT, Fox IH. Lymphocyte ecto-5′-nucleotidase deficiency in agammaglobulinemia. Science 1978;201:628-30.
12. Appelboom Th, Mandelbaum I, Vertongen F. Purine levels in rheumatoid arthritis. J Rheumatol 1985;12:1075-8.
13. Marinello E, Carlucci F, Tabucchi A, Leoncini R, Pizzichinini M, Pagani R. The purine nucleotide content of lymphocytes from patients with rheumatoid arthritis. Int J Clin Pharmacol Res 1994;14:57-63.
14. Kerstens PJSM, Stolk JN, Boerbooms AAMT, Lambooy LHJ, de Graaf R, De Abreu RA, et al. Purine enzymes in rheumatoid arthritis: Possible association with response to azathioprine. A pilot study. Ann Rheum Dis 1994;53:608-11.
15. Kerstens PJSM, Stolk JN, Boerbooms AAMT, De Abreu RA, van de Putte LBA. Purine enzymes in rheumatoid arthritis. A clue to the prediction of the response to azathioprine? Review and hypothesis. Clin Exp Rheumatol 1995;13:107-11.
16. Kerstens PJSM, Stolk JN, de Abreu RA, Lambooy LHJ, van de Putte LBA, Boerbooms AMT. Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:142-5.
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. van Ede AE, Laan RFJM, Rood MJ, Huizinga TWJ, van de Laar MAFJ, van Denderen CJ, et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate treatment in rheumatoid arthritis. A forty-eight-week, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2001;44:1515-24.
19. Van der Heijde DMFM, van't Hof MA, van Riel PLCM, Theunisse LM, Lubberts FW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: First step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
20. Ritchie DM, Boyle JA, McInness JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessments of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;147:393-406.
21. van Gestel AM, Prevoo MLL, van't Hof MA, van Rijswijk MH, van de Putte LBA, van Riel PLCM. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
22. Fries JF, Spitz PW, Williams CA, Bloch DA, Singh G, Hubert HB. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 1990;33:121-30.
23. Stolk JN, De Abreu RA, Boerbooms AMT, de Koning DGM, de Graaf R, Kerstens PJSM, et al. Purine enzyme activities in peripheral blood mononuclear cells: Comparison of a new non-radiochemical high-performance liquid chromatography procedure and a radiochemical thin-layer chromatography procedure. J Chromatogr B Biomed Appl 1995;666:33-43.
24. Stolk JN, Boerbooms AMTh, De Abreu RA, Kerstens PJSM, de Koning DGM, de Graaf R, et al. Purine enzyme activities in recent onset rheumatoid arthritis: Are there differences between patients and healthy controls? Ann Rheum Dis 1996;55:733-8.
25. Stolk JN, de Koning DGM, Pennings AH, De Abreu RA, van de Putte LBA, Boerbooms AMTh. Reduced purine 5′-nucleotidase activity in lymphocytes of patients with systemic lupus erythematosus: Results of a pilot study. Ann Rheum Dis 1999;58:122-5.